Robert Raya
9Patents
4h-index
16Co-inventors
50Inventor score
Filing activity: Jun 25, 2004 → Nov 4, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7628986B2 | Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof | Emerging Cross-Sectional Technologies | 60 | Expired |
| US7736644B2 | Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof | Emerging Cross-Sectional Technologies | 33 | Expired |
| US9096672B2 | Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof | Emerging Cross-Sectional Technologies | 13 | Active |
| US9062113B2 | Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof | Emerging Cross-Sectional Technologies | 6 | Active |
| US9073998B2 | Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof | Emerging Cross-Sectional Technologies | 3 | Active |
| US9085624B2 | Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof | Emerging Cross-Sectional Technologies | 2 | Active |
| US10118968B2 | Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US10508153B2 | Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US11492411B2 | Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.